Edgewater Capital Partners Acquires GL CHEMTEC

Edgewater Capital Partners Invests in CBCC Global Research

May 27, 2025

Healthcare Services

Edgewater Capital Partners, a Cleveland-based private equity firm, has partnered with the shareholders and management of CBCC Global Research, a Bakersfield-headquartered clinical contract research organization (CRO). Edgewater's investment will support CBCC's growth by funding people, technology, and infrastructure to expand its clinical trial services across oncology, CNS, ophthalmology and other therapeutic areas.

Edgewater Capital Partners Acquires Haematologic Technologies

October 11, 2019

Biotechnology

Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated, a Vermont-based provider of biologic products, reagents and GMP-compliant assay development and testing services for the biopharmaceutical industry. Edgewater said it will support HTI's next phase of growth and build the company as a premier outsourced services partner for biologics; financial terms were not disclosed.

Lakelet Capital Acquires GenTech Scientific

September 30, 2020

Industrial Services

Buffalo-based private equity firm Lakelet Capital has completed an investment to support the buyout of GenTech Scientific, a refurbisher, reseller, and servicer of analytical laboratory instrumentation based in Arcade, New York. The investment provides growth capital to enhance operations, extend geographic reach, and expand solution offerings; Lakelet also installed Michael Lippa as CEO and worked with GenTech founder Clair Bragg on the transition.

OpenGate Capital Acquires Chemisphere Corp.

January 18, 2022

Manufacturing

OpenGate Capital, a Los Angeles-based private equity firm, has acquired Chemisphere Corp., a specialty solvent blender and chemical distributor headquartered in St. Louis, Missouri, from founder Bob Schwent. The deal complements OpenGate’s recent acquisition of Chemsolv and creates a larger chemical distribution platform spanning the Midwest to the Mid‑Atlantic, with plans for organic growth and future add-on acquisitions.

Seatex Acquires ChemQuest Chemicals

September 7, 2022

Manufacturing

Seatex, a specialty chemical manufacturer backed by Cotton Creek Capital, has acquired ChemQuest Chemicals, a custom toll manufacturer headquartered in Pasadena, Texas. The deal, completed in September 2022, expands Seatex's production capacity and technical capabilities while providing continuity for ChemQuest customers; Edgewater Capital Partners, ChemQuest's private equity owner, sold the business.

Synalloy Corporation Acquires DanChem from Edgewater Capital Partners

October 28, 2021

Manufacturing

Synalloy Corporation (Nasdaq: SYNL) acquired DanChem, a specialty-chemicals contract manufacturer based in Danville, Virginia, for $32.95 million, closing October 22, 2021. DanChem operates three production plants on a 55-acre campus with over 120 employees, and is expected to generate approximately $30 million of 2021 revenue (c.18% adjusted EBITDA); the deal was funded through Synalloy's existing credit facility and DanChem was an Edgewater Capital Partners portfolio company.